Literature DB >> 21074457

Anticonvulsant activities of myo-inositol and scyllo-inositol on pentylenetetrazol induced seizures.

M Nozadze1, E Mikautadze, E Lepsveridze, E Mikeladze, N Kuchiashvili, T Kiguradze, M Kikvidze, R Solomonia.   

Abstract

Myo-inositol (MI) and its isomers are used for the treatment of various neuropathological conditions. The purpose of the present research was to study anticonvulsant properties of MI and scyllo-inositol (SCI) on pentylenetetrazol (PTZ) induced seizures in rats. Half an hour after treatment with MI (30 mg/kg) or SCI (5 mg/kg) seizures were induced in Wistar rats with PTZ (60 mg/kg). Control animals were treated either by normal saline or mannitol (control polyol of the same molecular weight, 30 mg/kg), given at the same time interval before PTZ injection, as MI/SCI groups. The anticonvulsant effects of MI/SCI treatment were assessed by the latent period (the time from PTZ-injection to the onset of first seizures), and the duration and severity (score) of seizures. The mortality rate was also assessed. Both MI and SCI treatment significantly reduced the seizure score, seizure duration and increased the latent period. These data suggest for strong potential of MI and SCI as the agents of antiepileptic therapy.
Copyright © 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21074457     DOI: 10.1016/j.seizure.2010.10.008

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  8 in total

Review 1.  The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry).

Authors:  Mark P Thomas; Stephen J Mills; Barry V L Potter
Journal:  Angew Chem Int Ed Engl       Date:  2015-12-22       Impact factor: 15.336

Review 2.  A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra.

Authors:  Caroline D Rae
Journal:  Neurochem Res       Date:  2013-11-21       Impact factor: 3.996

3.  Myo-inositol treatment and GABA-A receptor subunit changes after kainate-induced status epilepticus.

Authors:  Revaz Solomonia; Nana Gogichaishvili; Maia Nozadze; Eka Lepsveridze; David Dzneladze; Tamar Kiguradze
Journal:  Cell Mol Neurobiol       Date:  2012-09-18       Impact factor: 5.046

4.  The protective effect of myo-inositol on hippocamal cell loss and structural alterations in neurons and synapses triggered by kainic acid-induced status epilepticus.

Authors:  Nato Kotaria; Maia Kiladze; Mzia G Zhvania; Nadezhda J Japaridze; Tamar Bikashvili; Revaz O Solomonia; Tamar Bolkvadze
Journal:  Cell Mol Neurobiol       Date:  2013-04-09       Impact factor: 5.046

5.  Myoinositol Attenuates the Cell Loss and Biochemical Changes Induced by Kainic Acid Status Epilepticus.

Authors:  Lia Tsverava; Tamar Lordkipanidze; Eka Lepsveridze; Maia Nozadze; Marina Kikvidze; Revaz Solomonia
Journal:  Biomed Res Int       Date:  2016-08-23       Impact factor: 3.411

6.  Anticonvulsant effect of ethanolic extract of Cyperus articulatus L. leaves on pentylenetetrazol induced seizure in mice.

Authors:  Oscar Herrera-Calderon; Rocio Santiváñez-Acosta; Bertha Pari-Olarte; Edwin Enciso-Roca; Vicente Martin Campos Montes; Jorge Luis Arroyo Acevedo
Journal:  J Tradit Complement Med       Date:  2017-04-20

Review 7.  Isolation, Separation, and Preconcentration of Biologically Active Compounds from Plant Matrices by Extraction Techniques.

Authors:  Victoria Raks; Hossam Al-Suod; Bogusław Buszewski
Journal:  Chromatographia       Date:  2017-09-22       Impact factor: 2.044

8.  Myo-Inositol Limits Kainic Acid-Induced Epileptogenesis in Rats.

Authors:  Manana Kandashvili; Georgi Gamkrelidze; Lia Tsverava; Tamar Lordkipanidze; Eka Lepsveridze; Vincenzo Lagani; Maia Burjanadze; Manana Dashniani; Merab Kokaia; Revaz Solomonia
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.